
Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds on AlphaFold and deep learning models to model biological systems, generate candidate therapeutics, and simulate compound behavior. It operates as an AI-first drug discovery platform focused on strategic research collaborations with pharmaceutical companies, biotech firms, and CROs. Core technologies include machine learning, deep learning, and AlphaFold-derived protein-structure modeling. Isomorphic targets the biopharma market to shorten discovery timelines and increase predictive accuracy for therapeutic development.

Isomorphic Laboratories applies advanced AI to accelerate and improve drug discovery, enabling researchers to design molecules and predict their performance earlier in development. The company builds on AlphaFold and deep learning models to model biological systems, generate candidate therapeutics, and simulate compound behavior. It operates as an AI-first drug discovery platform focused on strategic research collaborations with pharmaceutical companies, biotech firms, and CROs. Core technologies include machine learning, deep learning, and AlphaFold-derived protein-structure modeling. Isomorphic targets the biopharma market to shorten discovery timelines and increase predictive accuracy for therapeutic development.
Core proposition: AI-first drug discovery platform building on AlphaFold to design and simulate therapeutic candidates
Founded: 2021
Headquarters: King's Cross, London
Notable founder/CEO: Sir Demis Hassabis
Recent funding: $600M external round (Mar 31, 2025) led by Thrive Capital
| Company |
|---|
Drug discovery and early-stage therapeutic design
2021
Biotechnology Research
$600,000,000
First external funding round; participation from GV and follow-on capital from Alphabet
“Led by Thrive Capital with participation from GV and follow-on capital from Alphabet”
Company Name: Isomorphic Labs (IsoLabs)
Founded: 2021
Leadership: Sir Demis Hassabis
Isomorphic Labs aims to advance human health by re-imagining drug discovery through the power of artificial intelligence. The company is built on the success of Google DeepMind’s AlphaFold and is focused on developing state-of-the-art technologies to accelerate and improve the process of designing and delivering new medicines.
Core Values:
Culture:
IsoLabs is committed to fostering a diverse and inclusive environment where collaboration is fundamental, learning is shared, and every employee feels supported.
Equal Employment Opportunity:
The company is committed to equal employment opportunities regardless of various protected characteristics.
Working Model:
IsoLabs follows a hybrid working model, requiring employees to be in the office three days a week (currently Tuesday, Wednesday, and one additional day).
Job Title: Research Scientist (Machine Learning)
Location: London
Employment Type: Full-time
Department: Research
As a Research Scientist in machine learning (ML), you will:
Essential:
Nice to Have: